Jason Rhodes is a Partner at Atlas Venture, where he invests in biotechnology and therapeutics across Seed, Series A, and later stages, with a focus on companies in the United States, particularly the Greater Boston area, Massachusetts, the East Coast, and New England. He serves on the boards of Rectify Pharma (Executive Chair), Generation Bio (Chairman), and Dyne Therapeutics (Chairman), and previously served as Chairman of Disarm Therapeutics (through 2020). He has invested in companies including Generation Bio, Dyne Therapeutics, Epizyme, Replimune, and Bicycle Therapeutics. Before Atlas Venture, he was President and CFO of Epizyme; earlier he was Vice President, Business Development at Alnylam Pharmaceuticals, and a Partner at Fidelity Biosciences (F-Prime). Rhodes holds a BA in History from Yale University and an MBA from The Wharton School, and lives in Cambridge, Massachusetts.
Jason Rhodes, Partner @ Atlas. Profile with intro opportunities and ranking information.
Not Yet Mapped
We've created a profile for Jason Rhodes from Atlas Venture. Our ranking analysis and additional data will be available once our research is complete.
Rankings and detailed information coming soon
Network Strength
No ranking data available yet.
How to get an intro to Jason
Map your path to Jason instantly
Connect your network and Draftboard will automatically find and score the strongest paths to Jason
That's it. Draftboard does the rest.
Rankings based on connection strength analysis - we ONLY show aggregate data, never specific connection data.